期刊文献+

低温心肺转流中不同氧合器对儿童罗库溴铵药效动力学的影响 被引量:1

Comparison of rocuronium pharmacodynamics between membrane and bubble oxygenator during hypothermic cardiopulmonary bypass in children
暂未订购
导出
摘要 目的研究先天性心脏病学龄儿童心肺转流(CPB)中,不同氧合器对其罗库溴铵药效动力学的影响。方法选择6~12岁先天性心脏病患儿46例,随机分为膜式氧合器组(MO组,n=22)和鼓泡式氧合器组(BO组,n=24)。诱导后静脉给罗库溴铵600μg/kg行气管插管。CPB前、中、后三阶段,肌颤搐反应强度(T1)25%时,静注罗库溴铵200μg/kg。监测两组诱导期、CPB前、中、后期罗库溴铵的起效时间、无反应时间、T110%、T125%、T175%恢复时间及恢复指数等指标。结果两组患儿CPB前罗库溴铵肌松时效比较差异无统计学意义。CPB中,MO组和BO组的起效时间、无反应时间、T110%、T110%~25%、T125%分别为(3.72±2.10)、(29.45±7.67)、(46.36±7.26)、(14.12±2.62)、(60.57±6.31)和(3.62±1.78)、(24.95±6.93)、(43.07±7.99)、(13.04±2.46)、(56.68±6.82)min,组间比较差异无统计学意义。结论低温CPB中使用膜式氧合器与鼓泡式氧合器对罗库溴铵维持量的肌松时效影响差异无统计学意义。 Objective To compare the effects bubble oxygenator (BO) on the pharmacodynamic hypothermic cardiopulmonary bypass(CPB). Methods between the membrane oxygenator(MO) and behaviour of rocuronium in children during Forty-six pediatric patients,6 to 12 years old, undergoing surgery for congenital heart disease, were randomly assigned to either group MO or group BO. After anesthesia was induced, a bolus dose of rocuronium 600μg/kg was administered, and then endotracheal intubation was performed. Weakened neuromuscular blockade was enhanced by intravenous injection of constant maintenance doses of rocuronium (200μg/kg) whenever the twitch tension attained 25% of the control during and after CPB. The onset time, no response time, and the time of twitch hight restoration of 10% and 25% of the control (T1 10%,T1 25%) were recorded. The time of the twitch tension returned to 75% of the control (T1 25%) and the recovery index were recorded before and after CPB. Results During CPB, the onset time, no response time, T, 10%, T1 10%-25%, T1 25% were(3.72±2.10),(29.45±7.67),(46.36±7.26),(14.12±2.62),(60.57± 6.31) rain in group MO and(3.62±1.78),(24.95±6.93) ,(43.07±7.99),(13.04±2.46) ,(56.68 ±6.82) rain in group BO, respectively. There were no significant differences between the two groups (P〉0.05). Conclusion The membrane and the bubble oxygenators have a similar effect on the pharmacodynamics of rocuronium during hypothermic CPB in pediatric patients.
出处 《临床麻醉学杂志》 CAS CSCD 2007年第10期806-808,共3页 Journal of Clinical Anesthesiology
关键词 罗库溴铵 心肺转流 氧合器 药效动力学 Rocuronium Cardiopulmonary bypass Oxygenator Pharmacodynamics
  • 相关文献

参考文献7

  • 1Cammu G,Coddens J,Hendrickx J,et al.Dose requirements of infusion of cisatracurium or rocuronium during hypothermic cardiopulmonary bypass.Br J Anaesth,2000,84:587-590.
  • 2Cammu G,Boussemaere V,Foubert L,et al.Large bolus dose vs.continuous infusion of cisatracurium during hypothermic cardiopulmonary bypass surgery.Eur J Anaesthesiol,2005,22:25-29.
  • 3Hall R.The pharmacokinetic behaviour of opioids administered during cardiac surgery.Can J Anaesth,1991,38:747-756.
  • 4徐凯智,岳静玲,孙冬梅.心内直视手术中体外循环对芬太尼药代动力学的影响[J].中华麻醉学杂志,2003,23(10):773-774. 被引量:6
  • 5冯正义,李桂芬,刘晋萍,李春华,龙村.改良超滤对婴幼儿心脏手术输血的影响[J].临床麻醉学杂志,2004,20(6):336-337. 被引量:7
  • 6Huber R,Mennicke C,Heitmann KU,et al.Membrane versus bubble oxygenator in hyperthermic regional perfusion:a prospective randomized clinical study.Eur Surg Res,1994,26:210-220.
  • 7Zimmermann AK,Weber N,Aehert H,et al.Effect of biopassive and bioactive surface-coatings on the hemocompatibility of membrane oxygenators.J Biomed Mater Res B Appl Biomater,2007,80:433-439.

二级参考文献12

  • 1徐凯智,胡小琴.心脏瓣膜置换术大剂量芬太尼麻醉的药代动力学研究[J].中华麻醉学杂志,1996,16(2):51-54. 被引量:23
  • 2Williams GD, Ramamoorthy C. The routine use of aprotinin during pediatric cardiac surgery is not a benefit. J Cardiothorac Vasc Anesth, 1999,13:785-788.
  • 3Naik SK, Knight A, Elliott MJ. A successful modification of ultrafiltration for cardiopulmonary bypass in children.Perfusion, 1991,6:41-50.
  • 4Chew MS, Brix-Christensen V, Ravn HB, et al. Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: a prospective, randomized study.Perfusion,2002,17:327-333.
  • 5Ootaki Y, Yamaguchi M, Oshima Y, et al. Effects of modified ultrafiltration on coagulation factors in pediatric cardiac surgery. Surg Today,2002,32:203-206.
  • 6Bently JB, Conahan TJ HI, Cork RC. Lung sequestration of fentanyl during cardiopulmonary bypass. Anesthesiology, 1982, 57: A244.
  • 7Micheisen LG, Holford NHG,W Lu,et al.The pharmacokinetics of remifentanil in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Anesth Analg, 2001,93 : 1100-1105.
  • 8Hall B. The phannacokinetic behaviour of opioids administered during cardiac surgery. Can J Anaesth, 1991,38:747-754.
  • 9Rosen DA, Rosen KR, Davidson B, et al. Abeorption of fentanyl by the membrane oxygenator. Anesthesiology, 1985,63: A281.
  • 10徐凯智,胡小琴,段宏谨,崔燕岩,刘欣,张亦忠.气相色谱-质谱检测血浆芬太尼浓度[J].西北药学杂志,1997,12(6):243-244. 被引量:14

共引文献11

同被引文献5

  • 1Cammu G, Coddens J, Hendfickx J, et al. Dose requirements of ci- satracurium or rocuronium during hypothermic cardiopulmonary by- pass. Br J Anaesth, 2000,84(5): 587-590.
  • 2Cammu G, Boussemaere V, Foubert L, et al. Large bolus dose vs.continuous infusion of cisatracurium during hypothermic cardiopulmo- nary bypass surgery. Eur J Anaesthesiol, 2005,22( 1 ) : 25-29.
  • 3Woestenborghs RJ, Timmerman PM, Coruelissen ML, et al. Assay methods for sufentanil in plasma Radioimmunoassay versus gas chrom- atography-mass spectrometry. Anesthesiology, 1994, 80(3): 666- 670.
  • 4Mehta NM, Halwick DR, Dodson BL, et al. Potential drug seques- tration during extracorporeal membrane oxygenation: results from an ex vivo experiment. Intensive Care Med, 2007, 33(6) : 1018-1024.
  • 5肖彬,张兴安,吴群林,王捷.酶联免疫吸附法测定人血清舒芬太尼浓度[J].中国临床药学杂志,2008,17(1):6-8. 被引量:5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部